-+ 0.00%
-+ 0.00%
-+ 0.00%

AC IMMUNE AG - DISCUSSIONS WITH FDA REGARDING ACI-7104 DEVELOPMENT PATH PLANNED FOR EARLY 2027

Reuters·09/23/2026 11:02:20